STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1],[2]

80% of Respondents Report InsufficientDigitalisation; Progress Stalled by Technology Knowledge and Funding Gaps

Celebrate Raya with daily free shipping,exciting deals and cashback giveaways from Taobao KUALA LUMPUR,Malaysia,March 4,2025--Taobao Malaysia is ushering in its first-ever sales campaign dedicated to

SINGAPORE,March 4,2025-- OceanBase,a leading provider of multi-cloud distributed database systems,today announced a collaboration with Atome,Southeast Asia\'s largest buy-now-pay-later provider and a

Unmatched Speed,Reliability,and Ruggedness for Professional Creators TAIPEI,March 4,2025-- Exascend,a global leader in advanced storage and memory solutions,proudly unveils its flagship Nitro Pro CFex

PARIS,March 4,2025--Zendure,a leading innovator in solar energy technology,has been named an official partner for UNESCO World Engineering Day for Sustainable Development (WED) 2025. This prestigious